Enterprise Value
$362.80 M
+$3.93 M+1.10%
Fri, 14 Mar 2025 23:27:00 GMT
Summary
- As of March 15, 2025, RIGL enterprise value is $362.80 million, with a rise of +$3.93 million (+1.10%) during the most recent trading day.
- Over the past year, RIGL enterprise value has increased by +$101.76 million (+38.98%).
- RIGL enterprise value is now -59.34% below its all-time high of $892.33 million.
Performance
RIGL Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RIGL Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +1.1% | +1.1% | +1.1% |
| 1 m1 month | -1.7% | -1.7% | -2.5% |
| 3 m3 months | +9.3% | +11.2% | +9.7% |
| 6 m6 months | +36.7% | +49.2% | +46.9% |
| ytdytd | +19.4% | +19.6% | +18.6% |
| 1 y1 year | +39.0% | +54.2% | +51.4% |
| 5 y5 years | +25.7% | +30.9% | +23.5% |
RIGL Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -15.6% | $343 M | +5.9% | |
| 3 m | 3-month | $437 M | -17.0% | $286 M | +27.0% |
| 6 m | 6-month | $504 M | -28.0% | $256 M | +41.5% |
| 1 y | 1-year | $504 M | -28.0% | $157 M | +131.4% |
| 3 y | 3-year | $604 M | -39.9% | $129 M | +181.9% |
| 5 y | 5-year | $844 M | -57.0% | $129 M | +181.9% |
| alltime | all time | $892 M | -59.3% | $5.67 M | +6295.1% |
Rigel Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $362.80 M(+19.4%) |
| 2024 | $303.76 M(+8.0%) |
| 2023 | $281.29 M(+1.5%) |
| 2022 | $277.19 M(-40.6%) |
| 2021 | $466.42 M(-22.4%) |
| 2020 | $601.32 M(+61.1%) |
| 2019 | $373.29 M(+21.1%) |
| 2018 | $308.17 M(-42.0%) |
| 2017 | $531.35 M(+143.0%) |
| 2016 | $218.63 M(-5.3%) |
| 2015 | $230.93 M(+25.1%) |
| 2014 | $184.65 M(-19.2%) |
| 2013 | $228.59 M(-57.1%) |
| Date | Value |
|---|---|
| 2012 | $532.93 M(-2.1%) |
| 2011 | $544.55 M(+41.2%) |
| 2010 | $385.52 M(-19.9%) |
| 2009 | $481.33 M(+92.5%) |
| 2008 | $250.06 M(-66.8%) |
| 2007 | $754.06 M(+197.4%) |
| 2006 | $253.52 M(+90.8%) |
| 2005 | $132.88 M(-71.8%) |
| 2004 | $471.73 M(+69.3%) |
| 2003 | $278.59 M(+846.4%) |
| 2002 | $29.44 M(-82.8%) |
| 2001 | $171.36 M(-47.8%) |
| 2000 | $328.09 M |
FAQ
- What is Rigel Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Rigel Pharmaceuticals?
- What is RIGL enterprise value year-to-date change?
- What is Rigel Pharmaceuticals enterprise value year-on-year change?
What is Rigel Pharmaceuticals enterprise value?
The current enterprise value of RIGL is $362.80 M
What is the all time high enterprise value for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high enterprise value is $892.33 M
What is RIGL enterprise value year-to-date change?
Rigel Pharmaceuticals enterprise value has changed by +$59.04 M (+19.44%) since the beginning of the year
What is Rigel Pharmaceuticals enterprise value year-on-year change?
Over the past year, RIGL enterprise value has changed by +$101.76 M (+38.98%)